• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconAstraZeneca

AstraZeneca

Page 11 of 13
Oxford-Vaccine-Trials-Kaiser-Health-News
HealthOxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing
By Jay Hancock, Kaiser Health NewsAugust 24, 2020
How reborn pharma giant AstraZeneca is taking the lead against COVID-19
MagazineHow reborn pharma giant AstraZeneca is taking the lead against COVID-19
By Jeremy KahnAugust 10, 2020
Britain's Prince William visiting an Oxford lab where they are working on a Covid-19 vaccine.
HealthA promising COVID-19 vaccine from Oxford and AstraZeneca just cleared a key safety hurdle
By Jeremy KahnJuly 20, 2020
AstraZeneca Gilead deal
HealthRumors swirl about an AstraZeneca and Gilead megadeal—but it doesn’t make sense
By Sy MukherjeeJune 8, 2020
AstraZeneca-Vaccine
HealthAstraZeneca agrees to provide 1.3 billion doses of its coronavirus vaccine to developing nations at cost
By Jeremy KahnJune 4, 2020
5 companies to keep an eye on following the world’s largest cancer conference
Health5 companies to keep an eye on following the world’s largest cancer conference
By Sy MukherjeeJune 3, 2020
British pharma giant AstraZeneca get $1 billion from the U.S. to make coronavirus vaccine
HealthBritish pharma giant AstraZeneca get $1 billion from the U.S. to make coronavirus vaccine
By John Lauerman and BloombergMay 21, 2020
AstraZeneca aims for 30 million doses of COVID-19 vaccine by September
HealthAstraZeneca aims for 30 million doses of COVID-19 vaccine by September
By Sara Marley and BloombergMay 18, 2020
In race to make a coronavirus vaccine, AstraZeneca joins forces with Oxford University
HealthIn race to make a coronavirus vaccine, AstraZeneca joins forces with Oxford University
By Marthe Fourcade, John Lauerman and BloombergApril 30, 2020
AstraZeneca coronavirus
HealthAstraZeneca stock slips on mixed earnings report and coronavirus uncertainty
By Sy MukherjeeFebruary 14, 2020
AstraZeneca - Factory
HealthAstraZeneca Will Pay Up to $6.9 Billion for Rights to Japanese Drugmaker’s Cancer Drug
By Don ReisingerMarch 29, 2019
Alzheimers-dementia-brain-research
HealthEli Lilly, AstraZeneca’s Alzheimer’s Drug Flop Is the Latest Disappointment in a Frustrating Disease
By Sy MukherjeeJune 12, 2018
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
HealthThis Company Beat the Odds to Become One of the World’s Most ‘Innovative’ Drug Giants
By Sy MukherjeeMarch 28, 2018
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
FinanceWhy Drug Giant AstraZeneca’s Stock Soared More Than 9% on Friday
By Sy MukherjeeMay 12, 2017
Man walks downstairs
HealthBig Pharma Just Had a Terrible, Horrible, No Good, Very Bad Week of Job Cuts
By Sy MukherjeeDecember 12, 2016
1...
  • 9
  • 10
  • 11
  • 12
  • 13
13
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
Economy
Jamie Dimon gets candid about national debt: ‘There will be a bond crisis, and then we’ll have to deal with it’placeholder alt text
By Eleanor PringleApril 29, 2026
Banking
‘They left me no choice’: Powell isn’t going anywhere—blocking Trump from another Fed appointeeplaceholder alt text
By Eva RoytburgApril 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.